首页|尿KIM-1、NGAL、RBP联合检测在慢性乙肝患者早期肾损伤中的预测价值

尿KIM-1、NGAL、RBP联合检测在慢性乙肝患者早期肾损伤中的预测价值

扫码查看
目的:探讨尿KIM-1、NGAL、RBP联合检测在慢性乙肝患者早期肾损伤中的预测价值。方法:纳入2021年1月至2022年7月北京大学人民医院收治的133例慢性乙肝患者作为研究组,按照尿微量白蛋白/肌酐(UACR)的水平分为无损伤组(UACR<30 mg/g,73例)和损伤组(UACR≥30 mg/g,60例)。选取同期进行体检的60例健康志愿者作为对照组。检测3组尿肾损伤分子1(KIM-1)、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、视黄醇结合蛋白(RBP)的水平。收集临床资料,分析尿KIM-1、NGAL、RBP与UACR的相关性。运用ROC曲线分析尿KIM-1、NGAL、RBP及联合检测对慢性乙肝患者早期肾损伤的预测价值。结果:损伤组尿KIM-1、NGAL、RBP的水平均明显高于无损伤组和对照组,差异有统计学意义(P<0.05);无损伤组和对照组尿KIM-1、NGAL、RBP的水平差异无统计学意义(P>0.05)。乙肝患者尿KIM-1、NGAL、RBP与UACR均呈正相关关系(r=0.589、0.359、0.519,P<0.05)。ROC曲线分析结果显示,KIM-1、NGAL、RBP对乙肝患者早期肾损伤均具有一定预测价值,曲线下面积分别为0.878、0.761、0.870,敏感度分别为73.33%、48.33%、78.33%,特异度分别为89.04%、94.52%、84.93。三者联合检测的曲线下面积0.980,敏感度91.70%,特异度97.30%均明显高于三者单独预测价值(P<0.05)。结论:尿KIM-1、NGAL、RBP的水平在慢性乙肝患者早期肾损伤时明显升高,联合检测对早期肾损伤具有更高的预测价值。
Predictive value of combined detection of urine KIM-1, NGAL, and RBP for early renal injury in patients with chronic hepatitis B
Objective:To evaluate the predictive value of combined detection of urine KIM-1, NGAL, and RBP for early renal injury in patients with chronic hepatitis B.Methods:One hundred and thirty-three chronic hepatitis B patients admitted to Peking University People's Hospitalfrom January 2021 to July 2022 were included, and based on the urinary albumin/creatinin ratio (UACR), they were divided into either a non-injury group (UACR<30 mg/g, 73 cases) or an injury group (UACR≥30 mg/g, 60 cases). Sixty healthy volunteers who underwent physical examination during the same period were selected as a control group. The urine levels of kidney injury molecule 1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and retinol binding protein (RBP) were detected in the three groups. Clinical data were collected. The correlation of urine KIM-1, NGAL, and RBP with UACR was analyzed. The predictive value of urine KIM-1, NGAL, and RBP, either alone or in combination, for early renal injury in patients with chronic hepatitis B was assessed by ROC curve analysis.Results:The urine levels of KIM-1, NGAL, and RBP in the injury group were significantly higher than those of the non-injury group and control group (P<0.05). There were no significant differences in urine KIM-1, NGAL, and RBP between the non-injury group and control group (P>0.05). Urine KIM-1, NGAL, and RBP were positively correlated with UACR in chronic hepatitis B patients (r=0.589, 0.359, and 0.519, respectively, P<0.05). ROC curve analysis showed that KIM-1, NGAL, and RBP had appreciated predictive value for early kidney injury in chronic hepatitis B patients; the area under the curve was 0.878, 0.761, and 0.870, the sensitivity was 73.33%, 48.33%, and 78.33%, and the specificity was 89.04%, 94.52%, and 84.93, respectively. The area under the curve, sensitivity (91.70%), and specificity (97.30%) of the three indexes combined were all significantly higher than those of any one of them alone (P<0.05).Conclusion:Urinary KIM-1, NGAL, and RBP levels are significantly increased in patients with chronic hepatitis B during early renal injury, and combined detection of them has higher predictive value for early renal injury in such patients.

连立超、范子玥、张昕、白丽

展开 >

100044 北京,北京大学人民医院肾内科

尿肾损伤分子1 中性粒细胞明胶酶相关脂质运载蛋白 视黄醇结合蛋白 慢性乙肝 早期肾损伤 预测价值

2023

中华临床医师杂志(电子版)
中华医学会

中华临床医师杂志(电子版)

CSTPCD
影响因子:0.99
ISSN:1674-0785
年,卷(期):2023.17(4)
  • 2